New Study Highlights Biopharma’s Current and Future Growth DriversIssue: July 26, 2016
| Category: Merck Topics
We recently sponsored a study that was conducted by the Economist Intelligence Unit (EIU), in which 254 global biopharmaceutical executives were asked how their companies will manage new risks associated with the changing biopharma landscape. This study, detailed in The Changing Biopharma Risk Equation, examines how new growth strategies are creating exposure to different types of risk and explores options for successfully navigating this unexplored territory. To download the report, access additional content on the changing nature of biopharma and explore how we can help companies overcome these challenges, click here for more information. In This Same Issue |
Recent Articles
Article Search
Article Archives
Events
Webinars
|